![](/img/cover-not-exists.png)
PSS2 A CANADIAN NETWORK META-ANALYSIS OF THE EFFICACY OF HALOBETASOL PROPIONATE (0.01%) AND TAZAROTENE (0.045%) FIXED COMBINATION RELATIVE TO OTHER TOPICAL THERAPIES AMONG PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
Lozano-Ortega, G., Rogula, B., Gaudet, V., Mickle, A., Johnston, K., Barbeau, M.Volume:
23
Journal:
Value in Health
DOI:
10.1016/j.jval.2020.04.1391
Date:
May, 2020
File:
PDF, 379 KB
2020